Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1/2 mutation carriers

By Domchek Susan  

Breast Cancer Research and Treatment, Vol. 124, Iss. 1, 2010-11 ,pp. : 195-203

Springer Publishing Company

Access to resources Recommend Favorite

Mammographic density does not differ between unaffected BRCA1/2 mutation carriers and women at low-to-average risk of breast cancer

By Gierach Gretchen   Loud Jennifer  

Breast Cancer Research and Treatment, Vol. 123, Iss. 1, 2010-08 ,pp. : 245-255

Springer Publishing Company

Access to resources Recommend Favorite

Chromosomal instability induced by mammography X-rays in primary human fibroblasts from BRCA1 and BRCA2 mutation carriers

By Frankenberg-Schwager Marlis   Gregus Anke  

International Journal of Radiation Biology, Vol. 88, Iss. 11, 2012-11 ,pp. : 846-857

Informa Healthcare

Access to resources Recommend Favorite

Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer

By Reding Kerryn  

Breast Cancer Research and Treatment, Vol. 123, Iss. 2, 2010-09 ,pp. : 491-498

Springer Publishing Company

Access to resources Recommend Favorite

Appendectomy and cancer risk in Jewish BRCA1 and BRCA2 mutation carriers

By Bernholtz Shiri  

Breast Cancer Research and Treatment, Vol. 131, Iss. 3, 2012-02 ,pp. : 981-985

Springer Publishing Company

Access to resources Recommend Favorite